From chemistry-request[ AT ]ccl.net Thu May 9 06:24:35 1991 Date: Tue, 7 May 91 21:31 EST From: SPELLMDC%ESVAX%dupont.com "-at-" RELAY.CS.NET Subject: Postdoctoral Fellowship Position To: chemistry%ccl.net: at :RELAY.CS.NET Status: R Postdoctoral Fellowship Molecular Modeling Applied to Drug Discovery A two-year position in The Du Pont Merck Pharmaceutical Company Postdoctoral Fewlloship Program is currently available in the molecular modeling group at DuPont Merck Pharmaceuticals. This position is part of a large team of structural biologists, biochemists, molecular biologists, and synthetic chemists aimed at drug discovery through rational drug design methods. Projects will be directed toward general solutions of specific chemical and biochemical problems encountered in the discovery process in our five thereapeutic areas. We use current molecular modeling and computer graphics techniques to construct and analyze models of synthetic targets. This includes small molecule modeling, protein modeling, and DNA modeling. Current modeling projects include ab initio, semi-empirical, molecular mechanical (Minimization and Dynamics), distance geometry, 3D-QSAR, and 3D-database modeling approaches. For examples of the types of approaches taken, please see: W. C. Ripka and J. M. Blaney, Topics in Stereochemistry, 20, 1-85. Our collaborations with synthetic chemistry, NMR spectroscopy, X-ray crystallography, and other disciplines is excellent. An interdisciplinary approach will be expected. We use both commercial and in-house packages and develop new methodologies when needed. Candidates should have good experience with Fortran and/or C programming. Experience with modeling packages such as Polygen's Quanta/Charm and Tripos's Sybyl/CoMFA is a must. The modeling group's graphics and computing hardware includes an IBM RS-6000/540, a Silicon Graphics 4D-340/GTXB, an SGI 4D-70/GT, an E&S PS390, access to the DuPont Vaxcluster and the DuPont Cray Y-MP. Interested individuals should send a CV, and three reference letters to: Dr. David Spellmeyer The Du Pont Merck Pharmaceutical Company Experimental Station P.O. Box 80353 Wilmington, DE 19880-0353 E-mail address: spellmdc%esvax -8 at 8- dupont.com